TEAGAN JONES: Open Payments
NPI 1467134049 · MANCHESTER, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 36 payments from 12 companies in 2025. Trend: 2023 $273 · 2024 $1,006 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 8 | $133 |
| Novo Nordisk Inc | 6 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $77 |
| ABBVIE INC. | 4 | $71 |
| Merck Sharp & Dohme LLC | 3 | $67 |
| Mannkind Corporation | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| PFIZER INC. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
Products named: MOUNJARO, TRINTELLIX, VRAYLAR, Wegovy, Ozempic, VERQUVO, AFREZZA, Auvelity.
Industry payments across TN — which companies pay providers there.
